98 related articles for article (PubMed ID: 3791258)
1. Vindesine for recurrent and metastatic cancer of the uterine cervix: a phase II study.
Rhomberg WU
Cancer Treat Rep; 1986 Dec; 70(12):1455-7. PubMed ID: 3791258
[TBL] [Abstract][Full Text] [Related]
2. [A phase II study of vindesine for pretreated non-small cell lung cancer].
Shimizu E; Nakamura Y; Yamasaki K; Kimura K; Inoue I; Nakahira S; Kawahito K; Tani K; Sone S; Yamashita T
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2532-6. PubMed ID: 3039921
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of vindesine in patients with non-small cell lung cancer.
Fujita J; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Futami H; Sakurai M; Ishihara J; Takahashi H
Jpn J Cancer Res; 1985 Sep; 76(9):902-5. PubMed ID: 2997097
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer.
Richel O; Zum Vörde Sive Vörding PJ; Rietbroek R; Van der Velden J; Van Dijk JD; Schilthuis MS; Westermann AM
Gynecol Oncol; 2004 Dec; 95(3):680-5. PubMed ID: 15581981
[TBL] [Abstract][Full Text] [Related]
5. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
Long HJ; Cross WG; Wieand HS; Webb MJ; Mailliard JA; Kugler JW; Tschetter LK; Kardinal CG; Ebbert LP; Rayson S
Gynecol Oncol; 1995 May; 57(2):235-9. PubMed ID: 7729741
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.
Morris M; Gershenson DM; Burke TW; Mitchell MF; Levenback C; Atkinson N; Wharton JT
Gynecol Oncol; 1994 May; 53(2):234-8. PubMed ID: 8188085
[TBL] [Abstract][Full Text] [Related]
10. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
[TBL] [Abstract][Full Text] [Related]
11. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
12. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
Hsiao SM; Chen CA; Hsu C; Lin HH; Hsieh CY; Wei LH
Anticancer Res; 2008; 28(3B):1887-91. PubMed ID: 18630476
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
[TBL] [Abstract][Full Text] [Related]
14. [A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer].
Ikeda K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Usui N; Nakada H; Adachi K; Yamazaki H; Tada A
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):536-40. PubMed ID: 4004284
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
Kelsen DP; Fein R; Coonley C; Heelan R; Bains M
Cancer Treat Rep; 1986 Feb; 70(2):255-9. PubMed ID: 3948190
[TBL] [Abstract][Full Text] [Related]
16. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
Wander HE; Nagel GA
Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Blessing JA; Valea FA; McGehee R; Manetta A; Webster KD; Andersen WA
Gynecol Oncol; 1997 Dec; 67(3):255-8. PubMed ID: 9441772
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of ifosfamide, 5-fluorouracil, and leucovorin in recurrent uterine cervical cancer.
Stornes I; Mejlholm I; Jakobsen A
Gynecol Oncol; 1994 Oct; 55(1):123-5. PubMed ID: 7959252
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of vindesine in patients with metastatic breast cancer.
Cobleigh MA; Williams SD; Einhorn LH
Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
[TBL] [Abstract][Full Text] [Related]
20. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study.
Piver MS; Ghamande SA; Eltabbakh GH; O'Neill-Coppola C
Gynecol Oncol; 1999 Dec; 75(3):334-7. PubMed ID: 10600285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
